期刊
PHARMACEUTICAL RESEARCH
卷 24, 期 6, 页码 1029-1046出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-006-9223-y
关键词
active targeting; cancer nanomedicine; micelle pharmacokinetics; polymer micelles; responsive drug release
资金
- NCI NIH HHS [R01-CA-90696] Funding Source: Medline
- NIBIB NIH HHS [R21-EB-005394] Funding Source: Medline
Polymer micelles are rapidly becoming a powerful nanomedicine platform for cancer therapeutic applications due to their small size (10-100 nm), in vivo stability, ability to solubilize water insoluble anticancer drugs, and prolonged blood circulation times. Recent data from clinical trials with three micelle formulations have highlighted these and other pharmacokinetic advantages with reduced systemic toxicity and patient morbidity compared to conventional drug formulation. While the initial anti-tumor efficacy of these systems seems promising, a strong research impetus has been placed on micelle functionalization in order to achieve tumor targeting and site-specific drug release, with the hope of reaching a more pronounced tumor response. Hence, the purpose of this review is to draw attention to the new developments of multi-functional polymer micelles for cancer therapy with special focus on tumor targeting and controlled drug release strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据